Israel Englander Myovant Sciences Ltd. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$24.03 - $27.02 $3.65 Million - $4.11 Million	152,094 Added 1121.22%	165,659 $4.47 Million
Q3 2022 Nov 14, 2022	SELL	$11.6 - $20.44 $2.92 Million - $5.15 Million	-251,823 Reduced 94.89%	13,565 $244,000
Q2 2022 Aug 15, 2022	BUY	$7.78 - $14.69 $1.57 Million - $2.96 Million	201,362 Added 314.5%	265,388 $3.3 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $16.4 $617,376 - $889,716	-54,251 Reduced 45.87%	64,026 $853,000
Q4 2021 Feb 14, 2022	SELL	$14.31 - $23.87 $939,050 - $1.57 Million	-65,622 Reduced 35.68%	118,277 $1.84 Million
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $673,506 - $959,764	-35,560 Reduced 16.2%	183,899 $4.13 Million
Q2 2021 Aug 16, 2021	BUY	$17.07 - $24.56 $3.4 Million - $4.89 Million	199,042 Added 974.88%	219,459 $5 Million
Q4 2020 Feb 16, 2021	SELL	$13.8 - $27.62 $7.49 Million - $15 Million	-542,577 Reduced 96.37%	20,417 $564,000
Q2 2020 Aug 14, 2020	BUY	$7.34 - $20.84 $4.13 Million - $11.7 Million	562,994 New	562,994 $11.6 Million
Q1 2020 May 14, 2020	SELL	$6.55 - $14.76 $2.37 Million - $5.34 Million	-361,591 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.2 - $19.21 $1.32 Million - $6.02 Million	313,588 Added 653.27%	361,591 $5.61 Million
Q3 2019 Nov 14, 2019	SELL	$5.19 - $9.46 $2.5 Million - $4.56 Million	-482,473 Reduced 90.95%	48,003 $249,000
Q2 2019 Aug 14, 2019	BUY	$8.69 - $25.0 $3.35 Million - $9.64 Million	385,715 Added 266.45%	530,476 $4.8 Million
Q1 2019 May 14, 2019	BUY	$16.83 - $24.45 $1.67 Million - $2.43 Million	99,487 Added 219.74%	144,761 $3.46 Million
Q4 2018 Feb 14, 2019	SELL	$15.01 - $25.2 $5.33 Million - $8.95 Million	-355,089 Reduced 88.69%	45,274 $743,000
Q3 2018 Nov 14, 2018	BUY	$19.33 - $26.78 $4.04 Million - $5.6 Million	208,927 Added 109.14%	400,363 $10.6 Million
Q2 2018 Aug 14, 2018	BUY	$19.2 - $25.14 $1.62 Million - $2.13 Million	84,568 Added 79.13%	191,436 $4.38 Million
Q1 2018 May 15, 2018	BUY	$12.46 - $21.32 $468,520 - $801,674	37,602 Added 54.29%	106,868 $2.27 Million
Q4 2017 Feb 14, 2018	SELL	$11.37 - $16.4 $348,672 - $502,922	-30,666 Reduced 30.69%	69,266 $876,000
Q3 2017 Nov 14, 2017	BUY	$9.93 - $15.47 $992,324 - $1.55 Million	99,932	99,932 $1.55 Million

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account